Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation

Seminars in Liver Disease

Volumn 20, Issue 4, 2000, Pages 481-495

  Faust, T W ^a  

^a Section of Gastroenterology   (United States)

Author keywords

Disease; Recurrent; Transplantation

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MITOCHONDRION ANTIBODY; TACROLIMUS;

ARTICLE; AUTOIMMUNE HEPATITIS; CHOLANGIOGRAPHY; FOLLOW UP; GRAFT FAILURE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER TRANSPLANTATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AGE FACTORS; CHILD; CHOLANGITIS, SCLEROSING; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT REJECTION; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS;

EID: 0034520944     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13157     Document Type: Article

References (60)

1. Primary biliary cirrhosis
2. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2
3. Primary biliary cirrhosis
4. Recurrence of primary biliary cirrhosis, autoimmune cholangitis and primary sclerosing cholangitis after liver transplantation
5. Recurrence of primary biliary cirrhosis after liver transplantation
6. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies
7. Primary biliary cirrhosis (PBC) after liver transplantation
8. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation
9. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation
10. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation
11. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis
12. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation
13. Recurrence of primary biliary cirrhosis after liver transplantation following fk506-based immunosuppression
14. Recurrence of primary biliary cirrhosis in the liver allograft: The effect of immunosuppression
15. Weaning of immunosuppression in liver transplant recipients
16. Graft and systemic disease in long-term survivors of liver transplantation
17. Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation
18. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation
19. Pathologic analysis of liver transplantation or primary biliary cirrhosis
20. Transplantation for primary biliary osis
21. Does liver transplantation cure primary biliary cirrhosis?
22. Liver transplantation for primary biliary cirrhosis
23. Is there recurrence of primary biliary cirrhosis after transplantation? A clinicopathologic study in long-term survivors
24. The antinuclear antibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis
25. Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis
26. Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation
27. Hepatic granulomas following liver transplantation
28. Primary sclerosing cholangitis
29. Sclerosing cholangitis following human orthotopic liver transplantation
30. Biliary strictures in hepatic transplantation
31. Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis?
32. Biliary strictures in hepatic transplants: Prevalence and types in patients with primary sclerosing cholangitis vs. those with other liver diseases
33. Intrahepatic biliary strictures after liver transplantation
34. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: Evidence of recurrent disease
35. Liver transplantation for sclerosing cholangitis
36. Biliary strictures after liver transplantation: Clinical picture, correlates and outcomes
37. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience
38. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation
39. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: Report of a case
40. Follow-up after liver transplantation for primary sclerosing cholangitis: Effects on survival, quality of life, and colitis
41. Recurrence of primary sclerosing cholangitis following liver transplantation
42. Orthotopic liver transplantation for primary sclerosing cholangitis
43. Biliary complications after liver transplantation in patients with preexisting sclerosing cholangitis
44. Intrahepatic bile duct strictures after human orthotopic liver transplantation
45. Hilar biliary strictures after liver transplantation: Cholangiography and percutaneous treatment
46. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis
47. Recurrent disease after liver transplantation
48. Autoimmune hepatitis
49. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting
50. Disease recurrence and rejection following transplantation for autoimmune chronic active liver disease
51. Recurrence of autoimmune hepatitis in children after liver transplantation
52. Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation
53. Liver transplantation for autoimmune hepatitis: A 12 year experience
54. Outcome of autoimmune hepatitis after liver transplantation
55. De-novo autoimmune hepatitis after liver transplantation
56. Recurrence of autoimmune hepatitis after liver transplantation
57. Liver transplantation for autoimmune hepatitis: Rejection and recurrence
58. Recurrence of autoimmune hepatitis after liver transplantation
59. Long-term follow-up after liver transplantation for autoimmune hepatitis: Evidence of recurrence of primary disease
60. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis